等待开盘 09-10 09:30:00 美东时间
+0.520
+4.77%
MBX Biosciences, Inc. (NASDAQ:MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today
09-04 20:05
MBX Biosciences has initiated its Phase 1 clinical trial of MBX 4291, a novel GLP-1/GIP co-agonist prodrug candidate for obesity treatment. The trial aims to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the drug, which is designed for monthly administration, improved weight loss, and better gastrointestinal tolerability. The study includes single and multiple ascending dose evaluations, with topline results expected in 2...
09-04 12:00
Microbix Biosystms ( ($TSE:MBX) ) just unveiled an announcement. Microbix Biosy...
09-04 01:38
My Foodie Box Limited ( ($AU:MBX) ) has provided an announcement. My Foodie Box...
09-01 14:28
My Foodie Box Limited ( ($AU:MBX) ) has shared an update. My Foodie Box Limited...
08-22 16:48
Jefferies analyst Roger Song assumes MBX Biosciences (NASDAQ:MBX) with a Buy rating and announces Price Target of $36.
08-15 20:18
Microbix Biosystems (TSX:MBX) Q3 EPS $(0.01) Down from $0.02 YoY, Sales $3.472M Down from $5.059M YoY
08-14 18:15
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
MBX Biosciences (NASDAQ:MBX) is set to give its latest quarterly earnings repor...
08-14 02:03
MBX Biosciences press release (NASDAQ:MBX): Q2 GAAP EPS of -$0.58. More on MBX Biosciences MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy Historical earnings data for ...
08-07 23:56